Editors’ Corner | Mother Nature Does Not Offer a Free Lunch!
It takes longer than we’d like to gain confidence in new percutaneous technology. Twenty years after Andreas Grüntzig’s first coronary PTCA, we were still debating whether stents were good or bad. Now we’re wondering about a return to balloons alone – albeit drug-coated. So it has been with left atrial appendage occlusion (LAAO).
Cover Story | Stroke Prevention in AFib: Defining the Role of LAAO
Left atrial appendage occlusion (LAAO) has become the most performed structural heart procedure in the U.S., with an estimated >700,000 procedures completed to date and volumes climbing sharply every year.
Feature | New Science From ESC Congress 2026
The ACC was live from ESC Congress 2026 in Munich, bringing members the latest cardiovascular science and clinical guidance. Below are standout studies in heart failure (HF), structural heart disease, dyslipidemia and prevention, and more, plus promising news in pulmonary embolism (PE).
Feature | POTS: Recognition Is Rising, But Management Gaps Remain
For many patients with postural orthostatic tachycardia syndrome (POTS), a form of dysautonomia, simply standing can trigger palpitations, dizziness, fatigue and exercise intolerance.
Feature | MedAxiom at 25: A Quarter Century Helping Cardiovascular Organizations Thrive
Twenty-five years ago, cardiovascular leaders faced a very different landscape. Independent cardiology practices were flourishing, fee-for-service reimbursement dominated, and consolidation, digital transformation and payment reform had yet to reshape the specialty.
